Literature DB >> 2212405

Specific immunotherapy in asthma.

J Bousquet1, A Hejjaoui, F B Michel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212405     DOI: 10.1016/s0091-6749(05)80091-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  13 in total

Review 1.  Immunotherapy for allergic diseases.

Authors:  J M Portnoy
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Pharmacotherapy of childhood asthma. An inflammatory disease.

Authors:  H P Van Bever; W J Stevens
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 3.  Asthma: a follow up statement from an international paediatric asthma consensus group.

Authors: 
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

Review 4.  Immunotherapy for mold allergy.

Authors:  H J Malling
Journal:  Clin Rev Allergy       Date:  1992

Review 5.  Clinical pharmacology of asthma. Implications for treatment.

Authors:  A J Frew; S T Holgate
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 6.  Specific immunotherapy in house dust mite allergy.

Authors:  J Bousquet; A Des Roches; L Paradis; H Dhivert; F B Michel
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 7.  Allergen immunotherapy for allergic respiratory diseases.

Authors:  Antonio Cappella; Stephen R Durham
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 8.  Seasonal allergic rhinitis. Newer treatment approaches.

Authors:  F Horak
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

Review 9.  Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.

Authors: 
Journal:  CMAJ       Date:  1995-05-01       Impact factor: 8.262

Review 10.  Safety considerations in assessing the role of immunotherapy in allergic disorders.

Authors:  J Bousquet; F B Michel
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.